A Study to Assess the Safety, Tolerability, and Blood and Urine Drug Levels of Fostamatinib Disodium (FosD) in Healthy Japanese and White Subjects
Clinical trial NCT01167868 · COMPLETED
Trial details
- NCT number
- NCT01167868
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2011-05-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.